RECOGNITION AND ASSESSMENT | TD SPOTLIGHT
Expert Panel Discussion: Tardive Dyskinesia Workup and Assessment
Join Dr. Andrew Cutler, Dr. Carlie Tanner, and Jeremy Schreiber for a clinical roundtable reviewing the DSM-5 diagnostic criteria for tardive dyskinesia (TD), emphasizing the importance of regular clinical assessments at every visit, discussing the Abnormal Involuntary Movement Scale (AIMS) examination to evaluate TD severity, and noting key questions and considerations for assessing the psychosocial impact of TD.
Faculty have been
compensated by Neurocrine
Biosciences, Inc.
Empty space, drag to resize
Write your awesome label here.
MED-MI-TD-US-0164

Up Next
Assessing Tardive Dyskinesia Using the Abnormal Involuntary Movement Scale (AIMS)
Build confidence in assessing tardive dyskinesia (TD) with this practical Abnormal Involuntary Movement Scale (AIMS) training module. Review the fundamentals of TD, learn how to conduct the AIMS, and watch expert-guided patient videos demonstrating proper examination techniques.

Up Next
Expert Panel Discussion: Distinguishing Tardive Dyskinesia from Other DRBA-Induced Movement Disorders
Join Dr. Andrew Cutler, Dr. Carlie Tanner, and Jeremy Schreiber for a clinical roundtable on differentiating tardive dyskinesia from other dopamine receptor-blocking agent (DRBA)-induced movement disorders. Using real patient videos, the panel demonstrates practical clinical assessment strategies to recognize and distinguish a variety of common movement disorders.
Your Resources on Tardive Dyskinesia and Other DIMDs
These
free educational resources are
sponsored and developed by
Neurocrine Biosciences, Inc.
Media Platforms

TD Dialogues® Podcast
Hear from experts in insightful conversations as they discuss the challenges of recognizing TD and share real-world strategies to effectively support patients
in managing symptoms.

Neurocrine Medical: Brave Science™ YouTube Channel
This channel features educational videos designed
to further understanding of TD, including content on the proposed mechanism of disease in TD and differentiating TD from drug-induced parkinsonism.
This educational
content was sponsored and developed
by Neurocrine Biosciences, Inc. This
non-CME program is intended to
provide general information about
drug-induced movement disorders and
not medical advice for any particular
patient.
LearnWorlds Privacy Policy | Terms & Conditions | Cookie Policy
Neurocrine Privacy Policy

Copyright © 2026
MED-MI-TD-US-0276



